XML 57 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2019
Summary of Significant Accounting Policies  
Schedule of impacts of error correction

 

 

 

 

 

 

 

Overstatement /

 

 

 

(Understatement) of

Period

 

 

Amortization Expense

Prior to fiscal year ended January 31, 2019

 

$

532,000

Three months ended April 30, 2019

 

$

(153,000)

Three months ended July 31, 2019

 

$

(165,000)

 

Fair Value of Liabilities on a Recurring Basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Quoted Prices in

    

Significant Other

    

Significant

 

 

Total Fair

 

Active Markets

 

Observable Inputs

 

Unobservable Inputs

 

 

Value

 

(Level 1)

 

 (Level 2)

 

(Level 3)

At October 31, 2019

 

 

  

 

 

  

 

 

  

 

 

  

Royalty liability (1)

 

$

953,000

 

$

 —

 

$

 —

 

$

953,000

 

 

 

 

 

 

 

 

 

 

 

 

 

At January 31, 2019

 

 

  

 

 

  

 

 

  

 

 

  

Royalty liability (1)

 

$

905,000

 

$

 —

 

$

 —

 

$

905,000


(1)

The fair value of the royalty liability was determined based on discounting the portion of the modified royalty commitment payable in cash (refer to Note 7 – Commitments and Contingencies for additional information on our royalty liability). Fair value adjustments are included within miscellaneous expense in the condensed consolidated statements of operations.

Schedule of Disaggregated Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended October 31, 2019

 

    

Recurring Revenue

    

Non-recurring Revenue

    

Total

Systems sales

 

$

27,000

 

$

1,019,000

 

$

1,046,000

Professional services

 

 

 —

 

 

1,615,000

 

 

1,615,000

Audit services

 

 

 —

 

 

1,266,000

 

 

1,266,000

Maintenance and support

 

 

8,537,000

 

 

 —

 

 

8,537,000

Software as a service

 

 

3,474,000

 

 

 —

 

 

3,474,000

Total revenue:

 

$

12,038,000

 

$

3,900,000

 

$

15,938,000

 

Schedule of Earnings Per Share, Basic and Diluted

 

 

 

 

 

 

 

 

 

Three Months Ended

 

    

October 31, 2019

    

October 31, 2018

Net loss

 

$

(164,000)

 

$

(678,000)

Add: redemption of Series A Convertible Preferred Stock

 

 

4,894,000

 

 

 —

Net income (loss) attributable to common shareholders

 

 

4,730,000

 

 

(678,000)

Weighted average shares outstanding - Basic (1)

 

 

21,598,146

 

 

19,655,882

Effect of dilutive securities - Stock options, Restricted stock and Series A Convertible Preferred Stock (2)

 

 

 —

 

 

 —

Weighted average shares outstanding - Diluted

 

 

21,598,146

 

 

19,655,882

Basic net income (loss) per share of common stock

 

$

0.22

 

$

(0.03)

Diluted net loss per share of common stock

 

$

(0.01)

 

$

(0.03)

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

    

October 31, 2019

    

October 31, 2018

Net loss

 

$

(459,000)

 

$

(2,768,000)

Add: redemption of Series A Convertible Preferred Stock

 

 

4,894,000

 

 

 —

Net income (loss) attributable to common shareholders

 

 

4,435,000

 

 

(2,768,000)

Weighted average shares outstanding - Basic (1)

 

 

20,435,055

 

 

19,495,745

Effect of dilutive securities - Stock options, Restricted stock and Series A Convertible Preferred Stock (2)

 

 

 —

 

 

 —

Weighted average shares outstanding - Diluted

 

 

20,435,055

 

 

19,495,745

Basic net income (loss) per share of common stock

 

$

0.22

 

$

(0.14)

Diluted net loss per share of common stock

 

$

(0.02)

 

$

(0.14)

 

 

 

 

 

 

 


(1)

Excludes 1,185,918 unvested restricted shares of common stock as of October 31, 2019, which are considered non-participating securities.

Diluted net loss per share excludes the effect of shares that are anti-dilutive. For the three and nine months ended October 31, 2019, diluted EPS excludes 2,895,464 shares of Series A Convertible Preferred Stock, 938,671 outstanding stock options and 1,185,918 unvested restricted shares of common stock. For the three and nine months ended October 31, 2018, diluted EPS excludes 2,895,464 shares of Series A Convertible Preferred Stock, 1,612,990 outstanding stock options and 2,239,047 unvested restricted shares of common stock.